000 01642 a2200457 4500
005 20250511212257.0
264 0 _c19910820
008 199108s 0 0 eng d
022 _a0066-4804
024 7 _a10.1128/AAC.35.5.916
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLivermore, D M
245 0 0 _aInvalidity for Pseudomonas aeruginosa of an accepted model of bacterial permeability to beta-lactam antibiotics.
_h[electronic resource]
260 _bAntimicrobial agents and chemotherapy
_cMay 1991
300 _a916-21 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnti-Bacterial Agents
_xmetabolism
650 0 4 _aAzlocillin
_xmetabolism
650 0 4 _aBacteria
_xgenetics
650 0 4 _aBacterial Proteins
650 0 4 _aCarrier Proteins
_xmetabolism
650 0 4 _aCell Membrane Permeability
650 0 4 _aChromosomes, Bacterial
_xenzymology
650 0 4 _aConjugation, Genetic
650 0 4 _aDrug Resistance, Microbial
_xgenetics
650 0 4 _aHexosyltransferases
650 0 4 _aHydrolysis
650 0 4 _aIndicators and Reagents
650 0 4 _aKinetics
650 0 4 _aMicrobial Sensitivity Tests
650 0 4 _aModels, Biological
650 0 4 _aMuramoylpentapeptide Carboxypeptidase
_xmetabolism
650 0 4 _aPenicillin-Binding Proteins
650 0 4 _aPeptidyl Transferases
650 0 4 _aPlasmids
650 0 4 _aPseudomonas aeruginosa
_xdrug effects
650 0 4 _aTransfection
700 1 _aDavy, K W
773 0 _tAntimicrobial agents and chemotherapy
_gvol. 35
_gno. 5
_gp. 916-21
856 4 0 _uhttps://doi.org/10.1128/AAC.35.5.916
_zAvailable from publisher's website
999 _c1912892
_d1912892